Home Healthcare Pharmaceuticals Diabetic Retinopathy Market

Diabetic Retinopathy Market Size, Share & Trends Analysis Report By Type (Proliferative Diabetic Retinopathy, Non-proliferative Diabetic Retinopathy), By Treatment Type (Anti-VEGF Drug, Steroid Implants, Laser Surgeries, Vitrectomy) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: July 30, 2026 | Author: Debashree B | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Diabetic Retinopathy Market, By Type 2022-2034 (USD MILLION/ Units)
    1. Proliferative Diabetic Retinopathy
    2. Non-proliferative Diabetic Retinopathy
  2. Diabetic Retinopathy Market, By Treatment Type 2022-2034 (USD MILLION/ Units)
    1. Anti-VEGF Drug
    2. Steroid Implants
    3. Laser Surgeries
    4. Vitrectomy
  3. Regional Diabetic Retinopathy Market
    1. North America
      1. North America Diabetic Retinopathy Market By Type 2022-2034 (USD MILLION/ Units)
        1. Proliferative Diabetic Retinopathy
        2. Non-proliferative Diabetic Retinopathy
      2. North America Diabetic Retinopathy Market By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Anti-VEGF Drug
        2. Steroid Implants
        3. Laser Surgeries
        4. Vitrectomy
      3. U.S.
        1. Proliferative Diabetic Retinopathy
        2. Non-proliferative Diabetic Retinopathy
        3. Anti-VEGF Drug
        4. Steroid Implants
        5. Laser Surgeries
        6. Vitrectomy
      4. Canada
        1. Proliferative Diabetic Retinopathy
        2. Non-proliferative Diabetic Retinopathy
        3. Anti-VEGF Drug
        4. Steroid Implants
        5. Laser Surgeries
        6. Vitrectomy
    2. Europe
      1. Europe Diabetic Retinopathy Market By Type 2022-2034 (USD MILLION/ Units)
        1. Proliferative Diabetic Retinopathy
        2. Non-proliferative Diabetic Retinopathy
      2. Europe Diabetic Retinopathy Market By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Anti-VEGF Drug
        2. Steroid Implants
        3. Laser Surgeries
        4. Vitrectomy
      3. U.K.
        1. Proliferative Diabetic Retinopathy
        2. Non-proliferative Diabetic Retinopathy
        3. Anti-VEGF Drug
        4. Steroid Implants
        5. Laser Surgeries
        6. Vitrectomy
      4. Germany
        1. Proliferative Diabetic Retinopathy
        2. Non-proliferative Diabetic Retinopathy
        3. Anti-VEGF Drug
        4. Steroid Implants
        5. Laser Surgeries
        6. Vitrectomy
      5. France
        1. Proliferative Diabetic Retinopathy
        2. Non-proliferative Diabetic Retinopathy
        3. Anti-VEGF Drug
        4. Steroid Implants
        5. Laser Surgeries
        6. Vitrectomy
      6. Spain
        1. Proliferative Diabetic Retinopathy
        2. Non-proliferative Diabetic Retinopathy
        3. Anti-VEGF Drug
        4. Steroid Implants
        5. Laser Surgeries
        6. Vitrectomy
      7. Italy
        1. Proliferative Diabetic Retinopathy
        2. Non-proliferative Diabetic Retinopathy
        3. Anti-VEGF Drug
        4. Steroid Implants
        5. Laser Surgeries
        6. Vitrectomy
      8. Russia
        1. Proliferative Diabetic Retinopathy
        2. Non-proliferative Diabetic Retinopathy
        3. Anti-VEGF Drug
        4. Steroid Implants
        5. Laser Surgeries
        6. Vitrectomy
      9. Nordic
        1. Proliferative Diabetic Retinopathy
        2. Non-proliferative Diabetic Retinopathy
        3. Anti-VEGF Drug
        4. Steroid Implants
        5. Laser Surgeries
        6. Vitrectomy
      10. Benelux
        1. Proliferative Diabetic Retinopathy
        2. Non-proliferative Diabetic Retinopathy
        3. Anti-VEGF Drug
        4. Steroid Implants
        5. Laser Surgeries
        6. Vitrectomy
      11. Rest of Europe
        1. Proliferative Diabetic Retinopathy
        2. Non-proliferative Diabetic Retinopathy
        3. Anti-VEGF Drug
        4. Steroid Implants
        5. Laser Surgeries
        6. Vitrectomy
    3. APAC
      1. APAC Diabetic Retinopathy Market By Type 2022-2034 (USD MILLION/ Units)
        1. Proliferative Diabetic Retinopathy
        2. Non-proliferative Diabetic Retinopathy
      2. APAC Diabetic Retinopathy Market By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Anti-VEGF Drug
        2. Steroid Implants
        3. Laser Surgeries
        4. Vitrectomy
      3. China
        1. Proliferative Diabetic Retinopathy
        2. Non-proliferative Diabetic Retinopathy
        3. Anti-VEGF Drug
        4. Steroid Implants
        5. Laser Surgeries
        6. Vitrectomy
      4. Korea
        1. Proliferative Diabetic Retinopathy
        2. Non-proliferative Diabetic Retinopathy
        3. Anti-VEGF Drug
        4. Steroid Implants
        5. Laser Surgeries
        6. Vitrectomy
      5. Japan
        1. Proliferative Diabetic Retinopathy
        2. Non-proliferative Diabetic Retinopathy
        3. Anti-VEGF Drug
        4. Steroid Implants
        5. Laser Surgeries
        6. Vitrectomy
      6. India
        1. Proliferative Diabetic Retinopathy
        2. Non-proliferative Diabetic Retinopathy
        3. Anti-VEGF Drug
        4. Steroid Implants
        5. Laser Surgeries
        6. Vitrectomy
      7. Australia
        1. Proliferative Diabetic Retinopathy
        2. Non-proliferative Diabetic Retinopathy
        3. Anti-VEGF Drug
        4. Steroid Implants
        5. Laser Surgeries
        6. Vitrectomy
      8. Singapore
        1. Proliferative Diabetic Retinopathy
        2. Non-proliferative Diabetic Retinopathy
        3. Anti-VEGF Drug
        4. Steroid Implants
        5. Laser Surgeries
        6. Vitrectomy
      9. Taiwan
        1. Proliferative Diabetic Retinopathy
        2. Non-proliferative Diabetic Retinopathy
        3. Anti-VEGF Drug
        4. Steroid Implants
        5. Laser Surgeries
        6. Vitrectomy
      10. South East Asia
        1. Proliferative Diabetic Retinopathy
        2. Non-proliferative Diabetic Retinopathy
        3. Anti-VEGF Drug
        4. Steroid Implants
        5. Laser Surgeries
        6. Vitrectomy
      11. Rest of Asia-Pacific
        1. Proliferative Diabetic Retinopathy
        2. Non-proliferative Diabetic Retinopathy
        3. Anti-VEGF Drug
        4. Steroid Implants
        5. Laser Surgeries
        6. Vitrectomy
    4. Middle East and Africa
      1. Middle East and Africa Diabetic Retinopathy Market By Type 2022-2034 (USD MILLION/ Units)
        1. Proliferative Diabetic Retinopathy
        2. Non-proliferative Diabetic Retinopathy
      2. Middle East and Africa Diabetic Retinopathy Market By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Anti-VEGF Drug
        2. Steroid Implants
        3. Laser Surgeries
        4. Vitrectomy
      3. UAE
        1. Proliferative Diabetic Retinopathy
        2. Non-proliferative Diabetic Retinopathy
        3. Anti-VEGF Drug
        4. Steroid Implants
        5. Laser Surgeries
        6. Vitrectomy
      4. Turkey
        1. Proliferative Diabetic Retinopathy
        2. Non-proliferative Diabetic Retinopathy
        3. Anti-VEGF Drug
        4. Steroid Implants
        5. Laser Surgeries
        6. Vitrectomy
      5. Saudi Arabia
        1. Proliferative Diabetic Retinopathy
        2. Non-proliferative Diabetic Retinopathy
        3. Anti-VEGF Drug
        4. Steroid Implants
        5. Laser Surgeries
        6. Vitrectomy
      6. South Africa
        1. Proliferative Diabetic Retinopathy
        2. Non-proliferative Diabetic Retinopathy
        3. Anti-VEGF Drug
        4. Steroid Implants
        5. Laser Surgeries
        6. Vitrectomy
      7. Egypt
        1. Proliferative Diabetic Retinopathy
        2. Non-proliferative Diabetic Retinopathy
        3. Anti-VEGF Drug
        4. Steroid Implants
        5. Laser Surgeries
        6. Vitrectomy
      8. Nigeria
        1. Proliferative Diabetic Retinopathy
        2. Non-proliferative Diabetic Retinopathy
        3. Anti-VEGF Drug
        4. Steroid Implants
        5. Laser Surgeries
        6. Vitrectomy
      9. Rest of MEA
        1. Proliferative Diabetic Retinopathy
        2. Non-proliferative Diabetic Retinopathy
        3. Anti-VEGF Drug
        4. Steroid Implants
        5. Laser Surgeries
        6. Vitrectomy
    5. LATAM
      1. LATAM Diabetic Retinopathy Market By Type 2022-2034 (USD MILLION/ Units)
        1. Proliferative Diabetic Retinopathy
        2. Non-proliferative Diabetic Retinopathy
      2. LATAM Diabetic Retinopathy Market By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Anti-VEGF Drug
        2. Steroid Implants
        3. Laser Surgeries
        4. Vitrectomy
      3. Brazil
        1. Proliferative Diabetic Retinopathy
        2. Non-proliferative Diabetic Retinopathy
        3. Anti-VEGF Drug
        4. Steroid Implants
        5. Laser Surgeries
        6. Vitrectomy
      4. Mexico
        1. Proliferative Diabetic Retinopathy
        2. Non-proliferative Diabetic Retinopathy
        3. Anti-VEGF Drug
        4. Steroid Implants
        5. Laser Surgeries
        6. Vitrectomy
      5. Argentina
        1. Proliferative Diabetic Retinopathy
        2. Non-proliferative Diabetic Retinopathy
        3. Anti-VEGF Drug
        4. Steroid Implants
        5. Laser Surgeries
        6. Vitrectomy
      6. Chile
        1. Proliferative Diabetic Retinopathy
        2. Non-proliferative Diabetic Retinopathy
        3. Anti-VEGF Drug
        4. Steroid Implants
        5. Laser Surgeries
        6. Vitrectomy
      7. Colombia
        1. Proliferative Diabetic Retinopathy
        2. Non-proliferative Diabetic Retinopathy
        3. Anti-VEGF Drug
        4. Steroid Implants
        5. Laser Surgeries
        6. Vitrectomy
      8. Rest of LATAM
        1. Proliferative Diabetic Retinopathy
        2. Non-proliferative Diabetic Retinopathy
        3. Anti-VEGF Drug
        4. Steroid Implants
        5. Laser Surgeries
        6. Vitrectomy
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.